Prevalence of endocrine complications and short stature in patients with thalassaemia major: A multicenter study by the Thalassaemia International Federation (TIF)

Pediatric Endocrinology Reviews

Volumn 2, Issue SUPPL. 2, 2004, Pages 249-255

  De Sanctis, Vincenzo ^a,b   Eleftheriou, Androulla ^b   Malaventura, Cristina ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b Thalassaemia International Federation   (Cyprus)

Author keywords

Endocrinopathies; Growth; Thalassaemias

Indexed keywords

IRON CHELATE; LIVER ENZYME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; DELAYED PUBERTY; DEVELOPING COUNTRY; ENDOCRINE DISEASE; ENDOCRINE GLAND; FEMALE; GEOGRAPHIC DISTRIBUTION; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INTERNATIONAL COOPERATION; IRON CHELATION; IRON OVERLOAD; LIFE EXPECTANCY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTICENTER STUDY; PATIENT COMPLIANCE; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; SHORT STATURE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BODY HEIGHT; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM DISEASES; FEMALE; GLUCOSE INTOLERANCE; HUMAN GROWTH HORMONE; HUMANS; HYPOPARATHYROIDISM; HYPOTHYROIDISM; INFANT; MALE; PUBERTY, DELAYED;

EID: 12544260252     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Wonke B, Modell B. Impact and future of screening for haemoglobin disorders. Curr Paediatr 1998;8:55-61
2. Angastiniotis M, Modell B. Global epidemiology of haemoglobin disorders. Ann N Y Acad Sci 1998;850:251-269
3. World Health Organization. Community control of hereditary anaemias. Bull WHO 1998;61:63-80
4. Wonke B. Management of beta-thalassaemia major. Curr Paediatr 1994;4:38-42
5. Italian Working Group on Endocrine Complications in Non-endocrine Disease. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995;42:581-586
6. Jensen CE, Tuck SM, Old J, Morris RW. Jardumian A, De Sanctis V, Hoffbrand AV, Wonke B. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with β-thalassaemia. Eur J Haematol 1997;59:76-81
7. Wonke B, De Sanctis V. Clinical aspects of transfusional iron overload. Rev Clin Exp Haematol 2000;4:322-336
8. Tanner JM. Growth at adolescence. 2nd edition. Oxford: Blackwell Science, 1973, p.32.
9. Zachmann M, Prader A, Kind HP, Hafliger H, Budlinger H. Testicular volume during adolescence: cross-sectional and longitudinal studies. Helv Paediatr Acta 1974;29:61-72
10. National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979; 28:1039-1057
11. Parfitt AM. The spectrum of hypoparathyroidism. J Clin Endocrinol Metab 1972;34:152-156
12. Nerup J. Addison's disease: clinical and serological studies. Acta Endocrinol 1974;76:127-142
13. Low LCK. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab 1997;10:175-184
14. Wilson RL. Iron, zinc, free radicals and oxygen in tissue disorders and cancer control. Ciba Found Symp 1977;51:331-354
15. Masala A, Meloni T, Gallisai D, Alagna S, Rovasio PP, Rassu S, Milia AF. Endocrine functioning in multitransfused prepubertal patients with homozygous β-thalassaemia. J Clin Endocrinol Metab 1984;58:667-670
16. Long RG. Endocrine aspects of liver disease. Br Med J 1980;1:225-228
17. Kattamis CA, Kattamis AC. Management of thalassaemia: growth and development, hormone substitution, vitamin supplementation and vaccination. Sem Hematol 1995;32:269-279
18. Grundy RG, Woods KA, Savage MO, Evans JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child 1994;71:128-132